NCT00409240

Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 103 (actual)
• Sponsor: Providence VA Medical Center · Federal
• Sex: All
• Age: 18 Years – 85 Years
• Healthy volunteers: Not accepted

Summary

Our study intends to test the efficacy of pharmacist-led group interventions on a weekly basis for 4-weeks, then on a monthly basis for 5 additional months to achieve concomitant reductions in hemoglobin A1c, lipids and blood pressure.

Detailed description

Our project intends to study the 6-month efficacy of a pharmacist-led group intervention program that simultaneously target diabetes, hypertension and dyslipidemia. We hypothesize that pharmacist-led group interventions on a weekly basis for 4-weeks then on a monthly basis for 5 additional months may achieve concomitant reductions in hemoglobin A1c, lipids and blood pressure. We are proposing a pilot randomized controlled study to test the efficacy and feasibility of this approach.

Conditions

• Diabetes
• Hypertension
• Dyslipidemia

Interventions

Type	Name	Description
OTHER	MEDIC	Multidisciplinary Education and Diabetes Intervention for Cardiac risk reduction (MEDIC; a pharmacist-led behavioral and pharmacologic intervention in groups.

Timeline

• Start date: 2006-10-01
• Primary completion: 2008-06-01
• Completion: 2008-06-01
• First posted: 2006-12-08
• Last updated: 2014-04-11
• Results posted: 2014-04-11

Locations

1 site across 1 country: United States